🧬🫀 What if our gut microbiome produces a natural cholesterol-lowering molecule that works on the same enzyme targeted by statins? A new Nature study reveals that Bacteroides uniformis, a common gut bacterium, produces pentadecanoic acid (C15:0), an odd-chain saturated fatty acid that directly inhibits HMG-CoA reductase (HMGCR) and protects against atherosclerosis in mice. The proposed mechanism: B. uniformis → C15:0 → HMGCR inhibition → hepatic cholesterol synthesis ↓ → SREBP2 activation → LDLR ↑ → circulating LDL-C ↓ → atherosclerosis ↓ 🔬 1. A microbial metabolite with anti-atherosclerotic activity Investigators analyzed gut metagenomes from 223 patients with atherosclerotic cardiovascular disease and 189 healthy controls. B. uniformis emerged as a prominent health-associated bacterial species. In high-fat-diet-fed Apoe⁻/⁻ mice, administering B. uniformis reduced atherosclerotic plaque burden, circulating LDL-C, total cholesterol and inflammatory macrophage accumulation. ⚡ 2. Pentadecanoic acid is the key effector Bioactivity-guided fractionation, mass spectrometry and NMR identified C15:0 as a major protective metabolite. Oral C15:0 supplementation reduced atherosclerotic plaque burden by approximately 50% in mice. The mechanistic evidence was particularly compelling: HMGCR inhibition: IC₅₀ = 15.53 μM Direct binding by SPR: Kd = 7.41 μM Binding confirmed by ITC: Kd = 6.11 μM Enzyme kinetics supported competitive inhibition of HMGCR. Notably, C15:0 was substantially less potent than atorvastatin in the purified enzyme assay, despite demonstrating meaningful activity in vivo. 🧪 3. Hepatic LDLR is essential C15:0 suppressed hepatic cholesterol biosynthesis, triggering compensatory SREBP2 activation and increased LDLR expression. Crucially, liver-specific Ldlr deletion abolished the lipid-lowering and anti-atherosclerotic effects. This establishes hepatic LDLR as a necessary mediator of protection in the experimental model. 🦠 4. Microbial biosynthesis matters The investigators identified C15:0-producing bacteria across several Bacteroidota genera. Deleting bacterial mutA or pta reduced C15:0 production and weakened atheroprotection. This provides functional evidence linking microbial biosynthetic capacity to host cardiovascular metabolism. 🌍 5. Human translational relevance Patients with dyslipidemia had significantly lower fecal and circulating C15:0 concentrations than healthy controls. However, these human findings are observational. Whether microbiome-derived C15:0 supplementation prevents cardiovascular events in humans remains unknown. 💡 The broader implication This study identifies a mechanistic connection between microbial lipid metabolism and a classical cardiovascular drug target. Rather than viewing gut bacteria only as regulators of inflammation, we should also consider them as endogenous producers of bioactive molecules capable of directly modulating host metabolic enzymes. Future therapies might combine microbiome engineering, microbial metabolite optimization and conventional lipid-lowering strategies. The gut microbiome may function as an endogenous metabolic drug factory. 📄 Yin C, Chen Y, Lin G, et al. A gut microbial odd-chain fatty acid alleviates atherosclerosis in mice. Nature. 2026. DOI: doi.org/10.1038/s41586-026-1… Data: PRJNA1213157 | PRJEB21528 | PRJNA615842 #GutMicrobiome #Atherosclerosis #CardiovascularDisease #PentadecanoicAcid #C15 #HMGCR #LDLR #SREBP2 #LipidMetabolism #Metabolomics #MicrobiomeTherapeutics

🧬 What if ageing is not simply a consequence of mitochondrial dysfunction—but a breakdown in communication between cellular organelles? A 2026 review in Nature Cell Biology by Mannino, Park & Wang proposes a broader framework for understanding ageing and longevity: Organelles are not merely metabolic factories. They are interconnected signalling hubs that coordinate cellular homeostasis, systemic metabolism and organismal longevity. 🔬 1. Lysosomes: Beyond cellular waste disposal Ageing disrupts lysosomal acidification, membrane integrity and degradative capacity, resulting in impaired proteostasis. However, lysosomes also coordinate longevity signalling through: AMPK–mTORC1–TFEB Lysosomal lipolysis and lipid-derived signalling ESCRT-mediated membrane repair In C. elegans, enhancing lysosomal lipolysis activates nuclear transcriptional programmes that extend lifespan. ⚡ 2. Mitochondria: More than ATP production Age-associated mitochondrial dysfunction involves reduced OXPHOS, declining NAD⁺, mtDNA damage and altered fission–fusion dynamics. Yet mitochondrial stress is not universally detrimental. Mild mitochondrial perturbations can activate protective programmes through: UPRmt NRF2/HSF1 ROS-dependent hormesis TCA metabolite–mediated epigenetic regulation The magnitude, timing and cellular context of mitochondrial stress determine whether adaptation or degeneration predominates. 🔗 3. Organelle contact sites: An emerging therapeutic frontier Mitochondria communicate directly with the endoplasmic reticulum and lysosomes. The ER–mitochondria interface coordinates calcium transfer through: IP3R → GRP75 → VDAC1 → MCU Excessive calcium transfer can promote cellular senescence, while disrupted contacts compromise mitochondrial homeostasis. Meanwhile, mitochondria–lysosome contacts regulate calcium, lipid exchange and mitochondrial dynamics through RAB7-dependent mechanisms. These findings suggest that restoring organelle communication—not simply increasing mitochondrial activity—could represent a therapeutic strategy. 🌍 4. Ageing is also a systemic communication problem Organelle stress in one tissue can influence distant organs. Examples include: Muscle mitochondrial stress → GDF15 → adipose/liver metabolic adaptation Muscle mitochondrial dysfunction → FGF21 → systemic metabolic remodelling Neuronal mitochondrial stress → Wnt signalling → intestinal UPRmt Lysosomal lipid signalling → neuronal responses → longevity regulation Remarkably, organelle-dependent signals can also influence epigenetic inheritance across generations in C. elegans. 💊 5. Implications for longevity therapeutics Rapamycin, metformin, dietary restriction, exercise and mitophagy-promoting interventions converge on overlapping organelle networks. Their benefits may involve coordinated improvements in: Lysosomal function + mitochondrial quality control + ER proteostasis + inter-organelle communication. These mechanisms are supported largely by experimental models; extending lifespan in humans remains unproven for most pharmacological interventions. 💡 The central insight: Perhaps the next generation of gerotherapeutics should move beyond targeting individual organelles toward restoring the integrated organelle network. For sarcopenia, metabolic disease and neurodegeneration, the crucial question may be not only whether mitochondria are dysfunctional, but whether mitochondria, lysosomes and the ER can still communicate effectively. Healthy ageing may depend as much on organelle coordination as on organelle function. 📄 Mannino P, Park M, Wang MC. Organellar insights in ageing and longevity. Nature Cell Biology. 2026;28:861–874. DOI: doi.org/10.1038/s41556-026-0… #Aging #Longevity #Geroscience #Mitochondria #Lysosomes #Autophagy #Mitophagy #Sarcopenia #Metabolism #CellBiology